author-photo

Atsushi Fukatsu

Kyoto University

98

Papers

3703

Citations

Citation Trend

Filter By

Papers (73) Sort By

Journal Conference Others

P1373ERYTHROPOETIN RESISTANCE IN PRE-DIALYSIS PERIOD AND ITS RELATION TO PROGNOSIS IN JAPANESE INCIDENT DIALYSIS PATIENTS

2020 Nephrology Dialysis Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study

2018 Journal of Diabetes Investigation
Show All
- Source
- Cite
- Save
Citations (35)
Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis

2016 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (3)
Influence of Renal Function on the 52-Week Efficacy and Safety of the Sodium Glucose Cotransporter 2 Inhibitor Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus

2016 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (41)
Adjusting the 17β–Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy

2016 Journal of The American Society of Nephrology
Show All
- Source
- Cite
- Save
Citations (18)
Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

2015 Endocrine Journal
Show All
- Source
- Cite
- Save
Citations (20)
Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus

2015 Journal of Diabetes Investigation
Show All
- Source
- Cite
- Save
Citations (38)
Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease.

2015 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (72)
Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males

2015 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (8)
Pharmacokinetics, Pharmacodynamics, and Safety of Luseogliflozin in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized, Single-blind, Placebo-controlled Trial

2015 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (15)